TIDMKYGA

RNS Number : 5363W

Kerry Group PLC

12 December 2023

12 December 2023

LEI: 635400TLVVBNXLFHWC59

KERRY GROUP

Kerry to acquire Lactase Enzymes Business

Kerry Group plc ("Kerry"), the global taste & nutrition company, announces it has entered into a definitive agreement to acquire part of the global lactase enzyme business of Chr. Hansen Holding A/S ("Chr. Hansen") and Novozymes A/S ("Novozymes") (together the "Lactase Enzymes Business") on a carve out basis (1). This acquisition is subject to European Commission approval of Kerry as a buyer and forms part of the Novozymes and Chr. Hansen merger approval process.

The Lactase Enzymes Business which includes NOLA(R) Products, further enhances Kerry's biotechnology solutions capability following the acquisitions of c-LEcta and Enmex (2) . This acquisition adds enzyme technology which helps create lactose-free and sugar reduced dairy products, while preserving their authentic clean taste. Global demand for lactase is being driven by increased awareness of lactose intolerance, while many consumers are also choosing lactose-free for lifestyle and health reasons.

The Lactase Enzymes Business had attributable revenue of approximately EUR40m in 2022 with sales in over 50 countries. Total consideration is EUR150m subject to routine closing adjustments, with the acquisition expected to close in the first half of 2024.

(1) Acquisition comprises certain trade and assets of Chr. Hansen's global lactase enzyme business and 100% of the share capital of Nuocheng Trillion Food (Tianjin) Co., Ltd, a Chinese subsidiary of Novozymes.

(2) Acquisition of c-LEcta GmbH completed in March 2022 and Enmex S.A. de C.V. in December 2021.

ENDS

About Kerry

Kerry is a world leading taste and nutrition partner for the food, beverage and pharmaceutical markets. We innovate with our customers to create great tasting products, with improved nutrition and functionality, while ensuring better impact for the planet. Our leading consumer insights, global RD&A team of 1,100+ food scientists and extensive global footprint enable us to solve our customers' complex challenges with differentiated solutions. At Kerry, we are driven to be our customers' most valued partner, creating a world of sustainable nutrition, and to reach over 2 billion consumers with sustainable nutrition solutions by 2030. For more information, visit www.kerry.com .

 
   CONTACT INFORMATION 
  ============================================= 
 
   Investor Relations 
   Marguerite Larkin , Chief Financial 
    Officer 
   +353 66 7182292 | investorrelations@kerry.ie 
 
   William Lynch , Head of Investor 
    Relations 
   +353 66 7182292 | investorrelations@kerry.ie 
 
   Media 
   Catherine Keogh , Chief Corporate 
    Affairs & Brand Officer 
   +353 45 930188 | corpaffairs@kerry.com 
 
   Website 
   www.kerry.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACQBLBDDDBBDGXD

(END) Dow Jones Newswires

December 12, 2023 11:13 ET (16:13 GMT)

Grafico Azioni Kerry (LSE:KYGA)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di Kerry
Grafico Azioni Kerry (LSE:KYGA)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di Kerry